Clinical trial

Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

NCT04613024

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Topamax Normalized identity: TopamaxView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gabapentin Normalized identity: gabapentinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2025-07-01

PhaseEARLY_PHASE1

Conditions

Weight Lossunresolved

Pain, Postoperativeunresolved

Interventions

TopamaxDRUG · verified · RxNorm: Topamax

GabapentinDRUG · verified · RxNorm: gabapentin

Sponsors & collaborators

Stanford Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04613024 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.